RFS
CBPO

Rockefeller Financial Services’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Rockefeller Financial Services’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-207
Closed -$19K – 577
2015
Q3 		$19K Buy
+207
New +$21.9K ﹤0.01% 458

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rockefeller Financial Services's CBPO Position: Q4 2015 in Review

Rockefeller Financial Services sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2015, closing a stake of 207 shares — an estimated $19K sold.

Rockefeller Financial Services first reported a position in CBPO in Q3 2015 and held it in 1 quarter. The position peaked at $19K in Q3 2015. 114 funds tracked by Wall St. Rank hold CBPO as of Q4 2015.

  • Rockefeller Financial Services reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 207 China Biologic Products Holdings, Inc. shares in Q4 2015, an estimated $19K.
  • Rockefeller Financial Services first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 1 quarter.
  • Rockefeller Financial Services's China Biologic Products Holdings, Inc. position peaked at $19K in Q3 2015.
  • 114 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2015.

Based on Rockefeller Financial Services's 13F filing for Q4 2015, filed 3 Feb 2016.